Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Biggest DTC Advertising Study Eyes Online Promotion

Jul 08 2013

• By Brenda Sandburg

Related Content

DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations

Jun 23 2009

Rx Firms Still Bear Promotional Compliance Burden If Social Media Platform Changes, FDA Says

Jun 27 2013

FDA May Allow "Qualitative" Labels For Data In DTC Ads

Aug 31 2010

The Drug Olympics: FDA To Test Consumer Comprehension Of Composite Endpoints

Aug 23 2012

FDA To Study Impact Of Rx Drug Ads That Provide Disease Information

Jun 20 2012

FDA Revises Prescriber DTC Survey To Focus On Patient Interactions

Oct 11 2012

FDA’s DTC Coupon Study Triggers First Amendment Objections From PhRMA

Jan 03 2011

DTC Comparative Ads Will Likely Bloom; FDA Studies How To Evaluate New Species

Dec 12 2011

FDA Advertising Studies Will Examine Website Formatting, Patient Testimonials, Outside Links

Apr 27 2011

Related Companies

Abbott

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Novartis AG

Eli Lilly and Company

Abbott

Genentech, Inc.

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window